- $16.14bn
- $18.71bn
- $8.25bn
ICON rises on upbeat 2023 profit forecast
LabCorp slips after Citi downgrades stock to 'neutral'
Quest Diagnostics, IQVIA slump after Citi downgrades
Icon Plc Reports Results For The Quarter Ended In September: Earnings Summary
Icon Plc Expected To Post Earnings Of $2.94 A Share: Earnings Preview
Contract research firms fall as Syneos sees large pharma award delays
Icon Plc Reports Results For The Quarter Ended In June: Earnings Summary
Icon Plc Expected To Post Earnings Of $2.79 A Share: Earnings Preview
CROs rise after IQVIA's upbeat results
Icon Plc Reports Results For The Quarter Ended In March: Earnings Summary
Icon Plc Expected To Post Earnings Of $2.70 A Share: Earnings Preview
Mizuho sees strong Q1 profit for health insurers
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Joann, Park Ohio Holdings
Baird says CROs to benefit as biotech funding 'fog' lifts
CRO investor concerns over dicey biotech funding environment overdone - Mizuho
Biotech related concerns are overblown, says Baird after decline in CRO stocks
U.S. RESEARCH ROUNDUP-American Water Works Company, First Horizon, Olaplex Holdings
Icon Plc Reports Results For The Quarter Ended In December: Earnings Summary
Icon Plc Expected To Post Earnings Of $2.62 A Share: Earnings Preview